Figure 1

Study population. (a) CCC (n = 13), mixed HCC and CCC (n = 56), metastatic cancer(n = 2), hepatoblastoma (n = 2), and sarcomatoid HCC (n = 2). CCC cholangiocellular carcinoma, HCC hepatocellular carcinoma.
Study population. (a) CCC (n = 13), mixed HCC and CCC (n = 56), metastatic cancer(n = 2), hepatoblastoma (n = 2), and sarcomatoid HCC (n = 2). CCC cholangiocellular carcinoma, HCC hepatocellular carcinoma.